DiaMedica Therapeutics Inc. (DMAC)
Market: NASD |
Currency: USD
Address: 301 Carlson Parkway
DiaMedica Therapeutics Inc., a clinical stage biopharmaceutical company, focuses on improving the lives of people suffering from serious diseases with a focus on acute ischemic stroke. Its lead candidate is DM199, a pharmaceutically active recombinant form of the human tissue kallikrein-1 protein, which is in Phase II/III trials for the treatment of acute ischemic stroke, as well as that is in Phase 2 to treat cardio-renal disease. The company also develops DM300, which is in preclinical stage for the treatment of severe inflammatory diseases. In addition, it develops treatment for neurological disease. The company was formerly known as DiaMedica Inc. and changed its name to DiaMedica Therapeutics Inc. in December 2016. DiaMedica Therapeutics Inc. was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.
Show more
📈 DiaMedica Therapeutics Inc. Historical Chart
📊 Statistics
-
Analyst 1 Year Price Target:
$9.67
-
Upside/Downside from Analyst Target:
153.05%
-
Broker Call:
6
-
Dividend Minimum 3 Year Yield:
0.00%
-
EPS Growth Range (1Y):
<0%
-
Net Income Growth Range (1Y):
<0%
-
Revenue Growth Range (1Y):
-
💰 Dividend History
| Year |
Annual Yield (%) |
Total Amount |
Current Yield (%) |
Ex Date |
Pay Date |
Particulars |
| 2018 |
- |
$0.050000 |
- |
2018-11-15 |
- |
Stock split |
|
Total Amount for 2018: $0.050000 |
📅 Earnings & EPS History for DiaMedica Therapeutics Inc.
| Date | Reported EPS |
|---|
| 2026-05-11 (estimated upcoming) | - |
| 2026-03-16 (estimated upcoming) | - |
| 2025-11-11 (estimated upcoming) | - |
| 2025-11-10 (estimated upcoming) | - |
| 2025-08-05 (estimated upcoming) | - |
| 2025-08-04 (estimated upcoming) | - |
| 2025-05-13 | - |
| 2025-05-13 | -0.18 |
| 2025-05-07 | - |
| 2025-05-06 | - |
| 2025-05-05 | - |
| 2025-03-17 | -0.18 |
| 2025-03-16 | - |
| 2024-11-13 | -0.15 |
| 2024-08-07 | -0.13 |
| 2024-08-06 | -0.13 |
| 2024-05-08 | -0.14 |
| 2024-05-07 | -0.14 |
| 2024-03-19 | -0.14 |
| 2024-03-18 | -0.14 |
| 2023-11-13 | -0.12 |
| 2023-11-12 | -0.12 |
| 2023-08-14 | -0.16 |
| 2023-08-13 | -0.16 |
| 2023-05-15 | -0.2 |
| 2023-05-14 | -0.2 |
| 2023-03-28 | -0.14 |
| 2023-03-27 | -0.14 |
| 2022-11-09 | -0.12 |
| 2022-11-08 | -0.12 |
| 2022-08-10 | -0.13 |
| 2022-08-09 | -0.13 |
| 2022-05-04 | -0.13 |
| 2022-05-03 | -0.13 |
| 2022-03-14 | -0.1 |
| 2022-03-13 | -0.1 |
| 2021-11-10 | -0.18 |
| 2021-11-09 | -0.18 |
| 2021-08-11 | -0.17 |
| 2021-08-10 | -0.17 |
| 2021-05-05 | -0.19 |
| 2021-05-04 | -0.19 |
| 2021-03-10 | -0.23 |
| 2021-03-09 | -0.23 |
| 2020-11-04 | -0.19 |
| 2020-11-03 | -0.19 |
| 2020-08-11 | -0.17 |
| 2020-08-10 | -0.17 |
| 2020-05-13 | -0.19 |
| 2020-05-12 | -0.19 |
| 2020-03-23 | -0.21 |
| 2020-03-22 | -0.21 |
| 2019-11-12 | -0.2 |
| 2019-08-12 | -0.21 |
| 2019-05-12 | -0.27 |
| 2019-03-18 | -0.23 |
| 2018-12-11 | - |
| 2018-12-09 | - |
📰 Related News & Research
No related articles found for "diamedica therapeutics".
